ECSP003721A - Una composicion farmaceutica para ser usada como anticonceptivo - Google Patents

Una composicion farmaceutica para ser usada como anticonceptivo

Info

Publication number
ECSP003721A
ECSP003721A EC2000003721A ECSP003721A ECSP003721A EC SP003721 A ECSP003721 A EC SP003721A EC 2000003721 A EC2000003721 A EC 2000003721A EC SP003721 A ECSP003721 A EC SP003721A EC SP003721 A ECSP003721 A EC SP003721A
Authority
EC
Ecuador
Prior art keywords
composition
daily
active agent
dosage units
pharmaceutical composition
Prior art date
Application number
EC2000003721A
Other languages
English (en)
Inventor
Ralph Lipp
Wolfgang Heil
Jurgen Hilman
Renate Heithecker
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8240592&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP003721(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of ECSP003721A publication Critical patent/ECSP003721A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invención se relaciona con una composición farmacéutica que comprende con un primer agente activo, 6B, 7B; 15B, 16B dimetilen-3-oxo-17a pregn-4-en-21, 17-carbolactona (drospirenona) en una cantidad correspondiente a una dosis diaria, a ser administrada con la composición, de desde aproximadamente 2mg a aproximadamente 4mg, y, como un segundo agente activo, 17 a-etinilestradiol (etinilestradiol) en una cantidad correspondiente a una dosis diaria desde aproximadamente 0.01mg a aproximadamente 0,05mg conjuntamente con uno o mas soportes o excipientes farmacéuticamente aceptables. En una realización específica, la composición consiste de un número de unidades de dosificación diarias colocadas en una unidad de empauqe, empaquetadas separadamente y separables individualmente, y proporcionadas para la administarción oral durante un periodo de al menos 21 días consecutivos, comprendiendo dichas unidades de dosificación diaria la combinación de drospirenona y etilestradiol. La composición puede comprender admés 7 o menos unidades de dosificación diaria que no contienen agente activo o que contienen solo etinilestradiol.
EC2000003721A 1999-08-31 2000-10-18 Una composicion farmaceutica para ser usada como anticonceptivo ECSP003721A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99202826 1999-08-31

Publications (1)

Publication Number Publication Date
ECSP003721A true ECSP003721A (es) 2002-05-23

Family

ID=8240592

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2000003721A ECSP003721A (es) 1999-08-31 2000-10-18 Una composicion farmaceutica para ser usada como anticonceptivo

Country Status (6)

Country Link
CN (1) CN1879632A (es)
AR (2) AR025443A1 (es)
CO (1) CO5200771A1 (es)
EC (1) ECSP003721A (es)
PE (1) PE20010665A1 (es)
ZA (2) ZA200201668B (es)

Also Published As

Publication number Publication date
AR043470A2 (es) 2005-07-27
ZA200404083B (en) 2006-02-22
AR025443A1 (es) 2002-11-27
CO5200771A1 (es) 2002-09-27
PE20010665A1 (es) 2001-06-19
ZA200201668B (en) 2004-06-24
CN1879632A (zh) 2006-12-20

Similar Documents

Publication Publication Date Title
YU14502A (sh) Farmaceutska kombinacija etinilestradiola i drospirenona za primenu kao kontraceptivnog sredstva
NO327588B1 (no) Farmasoytisk sammensetning og preparat omfattende etinylostradiol og drospirenon for anvendelse som antikonsepsjonsmiddel
UA41401C2 (uk) Фармацевтичний контрацептивний комбінований препарат
BG66095B1 (bg) Хидрофилен състав с контролирано освобождаване съдържащ прежелатинирано нишесте в препарат
HRP20090418T1 (en) Pharmaceutical composition containing gestagens and/or estrogens and 5-methyl-(6s)-tetrahydrofolate
AR022589A1 (es) UNA CÁPSULA QUE COMPRENDE UNA COMPOSICIoN FARMACÉUTICA ESPONTÁNEAMENTE DISPERSABLE PARA LA ADMINISTRACIoN ORAL, UNA COMPOSICIoN FARMACÉUTICA ESPONTÁNEAMENTE DISPERSABLE PARA LA ADMINISTRACIoN ORAL Y EL USO PARA LA PREPARACIoN DE UN MEDICAMENTO PARA EL TRATAMIENTO DEL CÁNCER
NZ307178A (en) Medicament for contraception; contains two, separately packed, sequential hormonal components
KR970706004A (ko) 호르몬 약물 및 에스트로겐 결핍을 치유하기 위한 그의 용도(novel hormonal medicaments and use thereof for correcting oestrogen deficiencies)
AR009113A1 (es) UN PRODUCTO ANTICONCEPTIVO PARA DETENER LA OVULACIoN EN MUJERES DURANTE SU PERIODO DE ACTIVIDAD OVÁRICA
HRP20080394T3 (en) Peroral solid dosage form for contraception comprising dienogest and ethinylestradiol
ECSP003721A (es) Una composicion farmaceutica para ser usada como anticonceptivo
DOP2006000035A (es) Preparación farmaceútica para la anticoncepción oral
RU2000115313A (ru) Схемы приема гестаген-анти-гестагена
CA2248841A1 (en) Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy
JO2213B1 (en) A pharmaceutical composition for use as a contraceptive method
CO5280075A1 (es) Drospirenona para terapia de reemplazo de hormonas
HRP20020666B1 (en) Drospirenone for hormone replacement therapy
TH54054B (th) สารผสมทางเภสัชกรรมสำหรับใช้เป็นยาคุมกำเนิด
UY29378A1 (es) Preparación farmaceutica para la anticoncepción oral